Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313507A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313503A1 Human tumor necrosis factor receptors tr21 and tr22
05/28/2003EP1313502A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS
05/28/2003EP1313458A1 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof
05/28/2003EP1313440A1 Dental products comprising bone growth enhancing peptide
05/28/2003EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor
05/28/2003EP1135500A4 Control of flowering
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0938332A4 Use of delta-like protein to inhibit the differentiation of stem cells
05/28/2003EP0928294B1 Method and apparatus for preparing an acellular red blood cell substitute
05/28/2003EP0909314A4 Plant sugar sensors and uses thereof
05/28/2003EP0894095B1 Insulin derivatives and their use
05/28/2003EP0871457B1 Isolated stromal cells and methods of using the same
05/28/2003EP0830604B1 Uses of apoptin
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0686162B1 Improved method for the refolding of proteins
05/28/2003EP0592546B1 Immunodeficiency virus recombinant poxvirus vaccine
05/28/2003EP0576476B1 Immunoassay for detection of mutant p53 polypeptide in biological fluids
05/28/2003EP0449958B9 Meningococcal class 1 outer-membrane protein vaccine
05/28/2003CN1420932A Apomixis conferred by expression of SERK interacting proteins
05/28/2003CN1420930A Novel compounds
05/28/2003CN1420929A Non-endogenous, constitutively activated known G protein-coupled receptors
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420892A Animal collagens and gelatins
05/28/2003CN1420793A Absorbents for dilated cardiomyopathy
05/28/2003CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules
05/28/2003CN1420176A High-efficiency expression recombinant hirudin and producing method thereof
05/28/2003CN1420127A Process for preparing uniform molecule weight polymerized hemoglobin
05/28/2003CN1420126A Method for preparing recombinant human plasminogen kringle 5 mutant protein rhpk-5
05/28/2003CN1420125A Trichina antigen gene Ts 87 and use thereof
05/27/2003US6570070 Generating herbicide resistant plants; obtain plant, incubate with vector coding preferential enzymatic polypeptides, transform plant, propagate, monitor transgentic plants response to herbicides
05/27/2003US6570069 Nucleotide sequences for use as gene transfer tools in genetic engineering
05/27/2003US6570062 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/27/2003US6570007 Insertion sequence element derived from ralstonia solanacearum
05/27/2003US6570005 Toxins active against pests
05/27/2003US6570003 Human 7TM proteins and polynucleotides encoding the same
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6570001 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
05/27/2003US6570000 Nucleotide sequence coding monoclonal antibody for use in the treatment of viral diseases
05/27/2003US6569998 Synthetic glycosulfopeptides and methods of synthesis thereof
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569994 Human blue-light photoreceptor hCRY2
05/27/2003US6569993 Process for the preparation of resin-bound cyclic peptides
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
05/27/2003US6569902 Inhibiting initiation or development of cancer by administering an effective dose of a nitrone free radical trapping agent to a subject
05/27/2003US6569833 Given amino acid sequence; useful treating hyperproliferative disorders and in drug screening and drug design
05/27/2003US6569831 Recombinant lactoferrin, methods of production from plants and uses
05/27/2003US6569681 Methods of improving homologous recombination
05/27/2003US6569679 Recombinant viral vector capable of expressing a gene product that activates a non-cytotoxic compound into a toxic product; use in treatment of viral diseases, cancer, genetic diseases
05/27/2003US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications
05/27/2003US6569668 Isolated nucleic acids from Micromonospora rosaria plasmid pMR2 and vectors made therefrom
05/27/2003US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease
05/27/2003US6569662 For use in therapeutic, diagnostic and research applications
05/27/2003US6569658 Proteins and nucleic acids which have an effect on or are related to cell cycle regulation; use in assays screening for cell cycle modulators and as therapeutics
05/27/2003US6569655 For use in therapeutics, diagnostics, and as research tools
05/27/2003US6569645 IL-17 homologous polypeptides and therapeutic uses thereof
05/27/2003US6569642 TNF-Related Apoptosis-Inducing Ligand (TRAIL); isolated DNA probe which hybridizes to nucleic acid of given sequence; use in purifying cells, inhibiting biological activities or as immunogens to produce antibodies
05/27/2003US6569641 Which can modify transcription, replication or stability of a DNA sequence; producing stochastically generated polynucleotide sequences; expression vectors
05/27/2003US6569622 Nucleic acids encoding a protein conferring an inducible resistance to glycopeptide, particularly in gram-positive bacteria
05/27/2003US6569617 Identifying a chemical agent which alters activity of a protein encoded by a mammalian gene, modifying the phenotypic alteration
05/27/2003US6569616 Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
05/27/2003US6569464 Antifertility agent comprises coelomic fluid extract which is obtained from an Indian earthworm, Pheretima posthuma, belonging to the phylum, Annelida
05/27/2003US6569435 Flavivirus and alphavirus recombinant antigen libraries
05/27/2003US6569434 Vascular endothelial cell growth factor C subunit
05/27/2003US6569433 Compounds and methods for the diagnosis and treatment of B. microti infection
05/27/2003US6569432 Isolated nucleic acid comprising a promoter sequence normally associated with the transcription of a gene encoding a human prostate-specific membrane antigen
05/27/2003US6569423 Regenerating nervous tissue by contacting tissue with an effective amount of Schwann cells expressing transcription factor Delta SCIP
05/27/2003US6569422 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003CA2274241C A process for purifying apolipoprotein a or apolipoprotein e from human plasma
05/27/2003CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
05/27/2003CA2199747C 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
05/27/2003CA2179208C Human cns receptor polynucleotides
05/27/2003CA2176229C Improved interferon polymer conjugates
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/27/2003CA2145169C A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
05/27/2003CA2140866C Use of inhibitors of fatty acid synthesis for treating cancer
05/27/2003CA2073493C Recombinant marek's disease virus, process for preparing the same and vaccine containing the same
05/27/2003CA2065424C Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobacteria infections and plasmides containing said fragments
05/27/2003CA2031430C Process for refolding recombinantly produced tgf-.beta.-like proteins
05/27/2003CA1341429C Hirudin variants, their use and processes for obtaining them
05/23/2003WO2002042475A1 Gene hd3a inducing flowering of plant and utilization thereof
05/22/2003WO2003042693A2 Method for measuring intracellular atp and/or gene expression
05/22/2003WO2003042661A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003WO2003042655A2 Diagnostic assay for antibiotic tolerance
05/22/2003WO2003042402A2 Agents that modulate immune cell activation and methods of use thereof
05/22/2003WO2003042401A2 Novel chromophores/fluorophores and methods for using the same
05/22/2003WO2003042400A2 Methods and compositions for regulating multi-drug resistance-associated protein 2
05/22/2003WO2003042399A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042388A1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state
05/22/2003WO2003042387A1 Novel hair keratin-associated proteins
05/22/2003WO2003042386A1 Desmin gene having novel point mutation causative of dilated cardiomyopathy
05/22/2003WO2003042383A1 Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
05/22/2003WO2003042370A2 New gene expressed in prostate cancer and methods of use
05/22/2003WO2003042369A2 Cellular kinase targets and inhibitors, and methods for their use
1 ... 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 ... 2916